Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine versus morphine for perioperative analgesia in tumor ablation
ChiCTR2100049250Phase 4Not yet recruiting
- Sponsor
- Zhongda Hospital, Southeast University
- Start
- Jul 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nalbuphine and morphine in pain (2 arms), sponsored by Zhongda Hospital, Southeast University. Primary endpoint: Effective analgesic ratio. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
nalbuphinemorphine
03
Conditions
pain
Beyond the preview
Go deeper on ChiCTR2100049250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049250.